Georgia A. McCann

Statistics

Publications

Citations

1.2K

H-Index

Active since

2010

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

The Ohio State University

The Ohio State University Wexner Medical Center

University of Alabama at Birmingham

Dartmouth College

Georgia A. McCann is an author at The University of Texas at San Antonio Health Science Center specializing in medicine, oncology, and gynecologic oncology.

Publications per year

2010–2024

Publications

Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer

Shaveta Vinayak, Sara M. Tolaney, Lee S. Schwartzberg et al. · JAMA Oncology · 2019 · 433 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

HO-3867, a Safe STAT3 Inhibitor, Is Selectively Cytotoxic to Ovarian Cancer

Kellie S. Rath, Shan K. Naidu, Pushpa Lata et al. · Cancer Research · 2014 · 98 citations

Medicine, Oncology, Pharmacology +11

TOPACIO/Keynote-162: Niraparib + pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a phase 2 trial.

Shaveta Vinayak, Sara M. Tolaney, Lee S. Schwartzberg et al. · Journal of Clinical Oncology · 2018 · 77 citations

Medicine, Oncology, Pharmacology +15

Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer

David M. O’Malley, Debra L. Richardson, Patrick S. Rheaume et al. · Gynecologic Oncology · 2011 · 51 citations

Medicine, Gynecology, Oncology +14

The impact of close surgical margins after radical hysterectomy for early-stage cervical cancer

Georgia A. McCann, Susanne Taege, Christina Boutsicaris et al. · Gynecologic Oncology · 2012 · 50 citations · Full text

Medicine, Oncology, Surgery +13

1–5 of 25